Cargando…

The effect of coronavirus disease 2019 immunity on frozen-thawed embryo transfer cycles outcome

OBJECTIVE: To study the effect of patients’ immunization after coronavirus disease 2019 (COVID-19) infection or messenger ribonucleic acid (mRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine on frozen-thawed embryo transfer (FET). DESIGN: Cohort retrospective study. SETTING:...

Descripción completa

Detalles Bibliográficos
Autores principales: Aizer, Adva, Noach-Hirsh, Meirav, Dratviman-Storobinsky, Olga, Nahum, Ravit, Machtinger, Ronit, Yung, Yuval, Haas, Jigal, Orvieto, Raoul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Reproductive Medicine, Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743570/
https://www.ncbi.nlm.nih.gov/pubmed/35216833
http://dx.doi.org/10.1016/j.fertnstert.2022.01.009
_version_ 1784629931893850112
author Aizer, Adva
Noach-Hirsh, Meirav
Dratviman-Storobinsky, Olga
Nahum, Ravit
Machtinger, Ronit
Yung, Yuval
Haas, Jigal
Orvieto, Raoul
author_facet Aizer, Adva
Noach-Hirsh, Meirav
Dratviman-Storobinsky, Olga
Nahum, Ravit
Machtinger, Ronit
Yung, Yuval
Haas, Jigal
Orvieto, Raoul
author_sort Aizer, Adva
collection PubMed
description OBJECTIVE: To study the effect of patients’ immunization after coronavirus disease 2019 (COVID-19) infection or messenger ribonucleic acid (mRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine on frozen-thawed embryo transfer (FET). DESIGN: Cohort retrospective study. SETTING: Tertiary university affiliated medical center. PATIENT(S): All consecutive patients undergoing FET cycles in our center. The study group (immune group) consisted of patients treated during the COVID-19 pandemic (between January 2021 and August 2021) who either recovered from COVID-19 infection or received the mRNA SARS-CoV-2 vaccine. The control groups consisted of patients treated during the COVID-19 pandemic (between January 2021 and August 2021) but were not infected or did not receive the mRNA SARS-CoV-2 vaccine (not-immune2021 group) and those treated between January 2019 and August 2019 (before the pandemic) (not-immune2019 group). INTERVENTION(S): Frozen-thawed embryo transfer cycles. MAIN OUTCOME MEASURE(S): Ongoing pregnancy rates and FET cycles’ characteristics. Data on patient age and variables related to infertility treatment were collected from the patient records. RESULT(S): During the study periods, 428 patients underwent 672 FET cycles. The immune group consisted of 141 patients who underwent 264 FET cycles (44 in postinfection and 220 in postvaccination), whereas the not-immune2021 and not-immune2019 groups consisted of 93 and 194 patients undergoing 125 and 283 FET cycles, respectively. Patients’ characteristics and the types of endometrial preparations were comparable between the study groups. The implantation rate and clinical and ongoing pregnancy rates per transfer were similar between the study groups (immune group, postinfection and postvaccination; not-immune2021 group; not-immune2019 group). CONCLUSION(S): Coronavirus disease 2019 infection or vaccination did not affect patients’ performance or implantation in their subsequent FET cycle.
format Online
Article
Text
id pubmed-8743570
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Reproductive Medicine, Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-87435702022-01-10 The effect of coronavirus disease 2019 immunity on frozen-thawed embryo transfer cycles outcome Aizer, Adva Noach-Hirsh, Meirav Dratviman-Storobinsky, Olga Nahum, Ravit Machtinger, Ronit Yung, Yuval Haas, Jigal Orvieto, Raoul Fertil Steril Original Article OBJECTIVE: To study the effect of patients’ immunization after coronavirus disease 2019 (COVID-19) infection or messenger ribonucleic acid (mRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine on frozen-thawed embryo transfer (FET). DESIGN: Cohort retrospective study. SETTING: Tertiary university affiliated medical center. PATIENT(S): All consecutive patients undergoing FET cycles in our center. The study group (immune group) consisted of patients treated during the COVID-19 pandemic (between January 2021 and August 2021) who either recovered from COVID-19 infection or received the mRNA SARS-CoV-2 vaccine. The control groups consisted of patients treated during the COVID-19 pandemic (between January 2021 and August 2021) but were not infected or did not receive the mRNA SARS-CoV-2 vaccine (not-immune2021 group) and those treated between January 2019 and August 2019 (before the pandemic) (not-immune2019 group). INTERVENTION(S): Frozen-thawed embryo transfer cycles. MAIN OUTCOME MEASURE(S): Ongoing pregnancy rates and FET cycles’ characteristics. Data on patient age and variables related to infertility treatment were collected from the patient records. RESULT(S): During the study periods, 428 patients underwent 672 FET cycles. The immune group consisted of 141 patients who underwent 264 FET cycles (44 in postinfection and 220 in postvaccination), whereas the not-immune2021 and not-immune2019 groups consisted of 93 and 194 patients undergoing 125 and 283 FET cycles, respectively. Patients’ characteristics and the types of endometrial preparations were comparable between the study groups. The implantation rate and clinical and ongoing pregnancy rates per transfer were similar between the study groups (immune group, postinfection and postvaccination; not-immune2021 group; not-immune2019 group). CONCLUSION(S): Coronavirus disease 2019 infection or vaccination did not affect patients’ performance or implantation in their subsequent FET cycle. American Society for Reproductive Medicine, Published by Elsevier Inc. 2022-05 2022-01-10 /pmc/articles/PMC8743570/ /pubmed/35216833 http://dx.doi.org/10.1016/j.fertnstert.2022.01.009 Text en ©2022 American Society for Reproductive Medicine, Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Aizer, Adva
Noach-Hirsh, Meirav
Dratviman-Storobinsky, Olga
Nahum, Ravit
Machtinger, Ronit
Yung, Yuval
Haas, Jigal
Orvieto, Raoul
The effect of coronavirus disease 2019 immunity on frozen-thawed embryo transfer cycles outcome
title The effect of coronavirus disease 2019 immunity on frozen-thawed embryo transfer cycles outcome
title_full The effect of coronavirus disease 2019 immunity on frozen-thawed embryo transfer cycles outcome
title_fullStr The effect of coronavirus disease 2019 immunity on frozen-thawed embryo transfer cycles outcome
title_full_unstemmed The effect of coronavirus disease 2019 immunity on frozen-thawed embryo transfer cycles outcome
title_short The effect of coronavirus disease 2019 immunity on frozen-thawed embryo transfer cycles outcome
title_sort effect of coronavirus disease 2019 immunity on frozen-thawed embryo transfer cycles outcome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743570/
https://www.ncbi.nlm.nih.gov/pubmed/35216833
http://dx.doi.org/10.1016/j.fertnstert.2022.01.009
work_keys_str_mv AT aizeradva theeffectofcoronavirusdisease2019immunityonfrozenthawedembryotransfercyclesoutcome
AT noachhirshmeirav theeffectofcoronavirusdisease2019immunityonfrozenthawedembryotransfercyclesoutcome
AT dratvimanstorobinskyolga theeffectofcoronavirusdisease2019immunityonfrozenthawedembryotransfercyclesoutcome
AT nahumravit theeffectofcoronavirusdisease2019immunityonfrozenthawedembryotransfercyclesoutcome
AT machtingerronit theeffectofcoronavirusdisease2019immunityonfrozenthawedembryotransfercyclesoutcome
AT yungyuval theeffectofcoronavirusdisease2019immunityonfrozenthawedembryotransfercyclesoutcome
AT haasjigal theeffectofcoronavirusdisease2019immunityonfrozenthawedembryotransfercyclesoutcome
AT orvietoraoul theeffectofcoronavirusdisease2019immunityonfrozenthawedembryotransfercyclesoutcome
AT aizeradva effectofcoronavirusdisease2019immunityonfrozenthawedembryotransfercyclesoutcome
AT noachhirshmeirav effectofcoronavirusdisease2019immunityonfrozenthawedembryotransfercyclesoutcome
AT dratvimanstorobinskyolga effectofcoronavirusdisease2019immunityonfrozenthawedembryotransfercyclesoutcome
AT nahumravit effectofcoronavirusdisease2019immunityonfrozenthawedembryotransfercyclesoutcome
AT machtingerronit effectofcoronavirusdisease2019immunityonfrozenthawedembryotransfercyclesoutcome
AT yungyuval effectofcoronavirusdisease2019immunityonfrozenthawedembryotransfercyclesoutcome
AT haasjigal effectofcoronavirusdisease2019immunityonfrozenthawedembryotransfercyclesoutcome
AT orvietoraoul effectofcoronavirusdisease2019immunityonfrozenthawedembryotransfercyclesoutcome